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The results presented in this review are based on my
thesis defended at Maastricht University on 23 Feb-
ruary 2006. The main aim of the study was to assess
if disease management programmes (DMPs) for
patients with asthma, Chronic Obstructive Pulmonary
Disease (COPD) or diabetes mellitus improve quality
of care without increasing total health care costs as
compared to usual care.
One of the most important elements of the DMPs was
the assignment of patients to one specific care provid-
er of a collaborative practice team, consisting of a gen-
eral practitioner (GP), nurse specialist and medical
specialist, as based on complexity of care. Patients
with low complexity of care were taken care of by the
GP, patients with medium complexity of care received
care from the nurse specialist, while the medical spe-
cialist treated patients with high complexity of care.
Principles of Health Technology Assessment (HTA)
and decision-analysis have been applied to explicitly
support decision-making regarding the DMPs.
Literature reviews were undertaken to investigate a
range of methodological issues in evaluating disease
management programmes. The impact of the disease
management programmes on processes and out-
comes of care was investigated empirically with quasi-
experimental designs. Patients with a diagnosis of
asthma, COPD or diabetes mellitus (type 1 or 2) and
without severe co-morbidity as heart failure, cancer or
end-stage renal disease, were eligible for inclusion. In
the asthmayCOPD study, 975 patients were included
of which 70% completed the 12-month data collection.
In the diabetes study, 473 patients were included of
which 52% completed two-year follow-up. In both stud-
ies, the main reason for dropping out was unwilling-
ness to fill out questionnaires. The long-term
cost-effectiveness of the disease management pro-
gramme for patients with asthma was assessed with
a fully probabilistic decision-analytic model.
The literature studies showed that several methodo-
logical challenges need to be uptaken in assessing the
cost-effectiveness of DMPs. The results of the empir-
ical studies showed that redesign of care according to
principles of disease management is associated with
improvements in quality of care, within the existing
budget restraints.
Another important finding was that patients assigned
to the nurse specialist benefit most from the imple-
mentation of the DMPs. The study indicated that the
increased attention to patient education and promotion
of self-management plays an important role herein as
does the combination of nursing and medical skills.
For the readers of the IJIC it is of special interest to
learn that in the short-term, disease control of patients
improved, as reflected in less exacerbations and hos-
pital admissions for patients with asthma or COPD and
better glycaemic control for patients with diabetes.
Self-management behaviour, disease-specific knowl-
edge and patient satisfaction improved for patients
with asthma, COPD and diabetes. Quality of life
improved for patients with COPD and diabetes, while
remaining stable in patients with asthma. Healthcare
costs decreased among patients with asthma and
remained equal for patients with COPD and diabetes.
In the long-term, there is a probability of 90% that the
asthma DMP is cost-effective as compared to usual
care.
Further observations related to integration of care are:
(1) continuous monitoring and optimisation of inte-
grated care is necessary because the processes of
care and the cost-effectiveness of DMPs are sensitive
to changes in the underlying guidelines, (2) existing
management and incentive structures in a particular
region need to be considered carefully when designing
a programme. If a programme does not ‘fit’ its envi-
ronment, it will not work optimally and might not fulfil
the expectations.
A conclusion relevant to integrated care is that the
long-term impact should be considered instead of
short-term results when deciding about adoption or
rejection of an integrated care programme, since the
largest benefits of these innovations are shown to
occur in the long-term.
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